Using cerebral stimulants to treat minimal brain dysfunction.
- 1 July 1975
- journal article
- Published by American Psychological Association (APA) in American Journal of Orthopsychiatry
- Vol. 45 (4), 564-572
- https://doi.org/10.1111/j.1939-0025.1975.tb01186.x
Abstract
This paper considers questions raised during a study of the medical records of 135 boys treated with CNS stimulants for minimal brain dysfunction. Among the questions: 1)Do physician factors contribute to child diagnosis, treatment choice, and clinical improvement? 2)What is improvement? 3)What kind of side effects occur and how frequent are they? 4)When should cerebral stimulants be used.Keywords
Funding Information
- National Institute of Mental Health (MH 22659)
This publication has 15 references indexed in Scilit:
- THE STATE-DEPENDENT EFFECTS OF METHYLPHENIDATE AND DEXTROAMPHETAMINEJournal of Nervous & Mental Disease, 1974
- Amphetamines in the Treatment of Hyperkinetic ChildrenHarvard Educational Review, 1973
- What Parents Need To Know About Stimulant Drugs And Special EducationJournal of Learning Disabilities, 1973
- DRUG THERAPY: INITIATION AND FOLLOW‐UPAnnals of the New York Academy of Sciences, 1973
- Levoamphetamine and Dextroamphetamine: Comparative Efficacy in the Hyperkinetic SyndromeArchives of General Psychiatry, 1972
- Depression of Growth in Hyperactive Children on Stimulant DrugsNew England Journal of Medicine, 1972
- Characteristics of children referred because of hyperactivityThe Journal of Pediatrics, 1971
- The "One Child, One Drug" Myth of Stimulants in HyperkinesisArchives of General Psychiatry, 1971
- SENSITIVITY OF SYMPTOM AND NONSYMPTOM-FOCUSED CRITERIA OF OUTPATIENT DRUG EFFICACYAmerican Journal of Psychiatry, 1965
- THE EFFECTS OF METHYLPHENIDATE ON SYMPTOMATOLOGy AND LEARNING IN DISTURBED CHILDRENAmerican Journal of Psychiatry, 1963